Clinical Trial Update: Study of Prophylactic Vs Preemptive Valganciclovir [NA]

View source ↗

Summary

A completed clinical trial comparing prophylactic versus preemptive valganciclovir for cytomegalovirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cytomegalovirus Infection | NA | Status: COMPLETED